Integrative Multi-Omics Analysis in Calcific Aortic Valve Disease Reveals a Link to the Formation of Amyloid-Like Deposits
Open Access
- 24 September 2020
- Vol. 9 (10), 2164
- https://doi.org/10.3390/cells9102164
Abstract
Calcific aortic valve disease (CAVD) is the most prevalent valvular heart disease in the developed world, yet no pharmacological therapy exists. Here, we hypothesize that the integration of multiple omic data represents an approach towards unveiling novel molecular networks in CAVD. Databases were searched for CAVD omic studies. Differentially expressed molecules from calcified and control samples were retrieved, identifying 32 micro RNAs (miRNA), 596 mRNAs and 80 proteins. Over-representation pathway analysis revealed platelet degranulation and complement/coagulation cascade as dysregulated pathways. Multi-omics integration of overlapping proteome/transcriptome molecules, with the miRNAs, identified a CAVD protein–protein interaction network containing seven seed genes (apolipoprotein A1 (APOA1), hemoglobin subunit β (HBB), transferrin (TF), α-2-macroglobulin (A2M), transforming growth factor β-induced protein (TGFBI), serpin family A member 1 (SERPINA1), lipopolysaccharide binding protein (LBP), inter-α-trypsin inhibitor heavy chain 3 (ITIH3) and immunoglobulin κ constant (IGKC)), four input miRNAs (miR-335-5p, miR-3663-3p, miR-21-5p, miR-93-5p) and two connector genes (amyloid beta precursor protein (APP) and transthyretin (TTR)). In a metabolite–gene–disease network, Alzheimer’s disease exhibited the highest degree of betweenness. To further strengthen the associations based on the multi-omics approach, we validated the presence of APP and TTR in calcified valves from CAVD patients by immunohistochemistry. Our study suggests a novel molecular CAVD network potentially linked to the formation of amyloid-like structures. Further investigations on the associated mechanisms and therapeutic potential of targeting amyloid-like deposits in CAVD may offer significant health benefits.Funding Information
- Deutsche Forschungsgemeinschaft (GO1801/5-1 to CG; SFB/TRR219 C02 to CG)
This publication has 90 references indexed in Scilit:
- Identification of Altered Plasma Proteins by Proteomic Study in Valvular Heart Diseases and the Potential Clinical SignificancePLOS ONE, 2013
- Aβ Association Inhibition by TransferrinBiophysical Journal, 2013
- Protease‐activated alpha‐2‐macroglobulin can inhibit amyloid formation via two distinct mechanismsFEBS Letters, 2013
- 5-HT2B antagonism arrests non-canonical TGF-β1-induced valvular myofibroblast differentiationJournal of Molecular and Cellular Cardiology, 2012
- Factor XIII expression within aortic valves and its plasma activity in patients with aortic stenosis: association with severity of diseaseThrombosis and Haemostasis, 2012
- Refining Molecular Pathways Leading to Calcific Aortic Valve Stenosis by Studying Gene Expression Profile of Normal and Calcified Stenotic Human Aortic ValvesCirculation: Cardiovascular Genetics, 2009
- Serotonergic drugs and valvular heart diseaseExpert Opinion on Drug Safety, 2009
- Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicityProceedings of the National Academy of Sciences of the United States of America, 2008
- The Emerging Role of Valve Interstitial Cell Phenotypes in Regulating Heart Valve PathobiologyThe American Journal of Pathology, 2007
- Structural Studies of the Alzheimer’s Amyloid Precursor Protein Copper-binding Domain Reveal How it Binds Copper IonsJournal of Molecular Biology, 2007